Kerala: Dr Mahesh Kappanayil, Professor of Paediatric Cardiology at Amrita Institute of Medical Sciences, Kochi has recently been recognised as a face for his innovative work in the field of 3D Printing technology applied in congenial heart surgery.
His world has been recently showcased at the “Festival of Innovations 2016” at Rashtrapati Bhavan, New Delhi, from 12th-19th March 2016, organised by the Office of the President of India and the National Innovation Foundation (NIF).
This event is a high stature platform recognizing the spirit of innovation, and was in addition marked by the presence of government dignitaries including the President Pranab Mukherjee, who also inaugurated the event. List of other attendees included Union Ministers, senior government officials, heads of major scientific bodies (Indian Council of Medical Research, Department of Biotechnology, Department of Science & Technology), and by grassroots innovators.
Dr Mahesh and the pediatric cardiac unit at AIMS has received accolades for pioneering in using the 3D printing technology benefitting many clinical patients; and, also being applicable for more research and training.
As reported by Express, in a path-breaking effort in 2015, three children with extremely complex heart diseases were successfully operated at AIMS after creating 3D printed replicas of their hearts using their cardiac MRI scans. These precise 3D-printed heart models, created by AIMS in collaboration with Materialise (Belgium) and Sahas LLP (Mumbai) enabled the surgeons to understand the nature of the defects in great detail, allowing them to meticulously plan the complex surgeries.
This is also the first time that a technology like 3D finds a breakthrough in health care. It is now expected to add lot of research value to revolutionise medicine, while making use of surgical planning, customized prosthetics and implants, development of newer medical devices, as well as medical education and training. More specifically, the use of biological 3D printing may also help in creating patient-specific organs and tissues for therapy and transplantation.